Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

FILOVAX

Financiado

Cerrado

Development of Broadly Protective Filovirus Vaccines

The overall objective of the proposed broadly protective Filovirus vaccine project is to leverage co-funding from the European Commission to support the development of vaccines that will protect against a range of Filoviruses. Wit... ver más

31/10/2029

Innovasjon Norge

50M€

Presupuesto del proyecto: 50M€

Líder del proyecto

Innovasjon Norge No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-04-03 No tenemos la información de la convocatoria

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

Innovasjon Norge

35.00M€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

BES-2017-082074 EVOLUCION DEL VIRUS INFLUENZA PORCINA ASOCIADA A LA VACUNACI... 93K€ Cerrado

EbolaVac Development of a Chimpanzee Adenovirus Type 3 Ebolavirus Zai... 22M€ Cerrado

AGL2014-57430-R MEJORA Y EVALUACION DE VACUNAS BASADAS EN VECTORES VIRICOS Y... 303K€ Cerrado

HAR2012-39655-C04-03 INTERNACIONALIZACION Y ESTRATEGIAS CONTRA LA ENFERMEDAD: PRO... 35K€ Cerrado

MARVAX Development of novel viral vectored vaccines against Marburg... 7M€ Cerrado

PEVIA PAN EBOLA VACCINE INNOVATIVE APPROACH Sofia ref. 116088 18M€ Cerrado

Duración del proyecto: 66 meses Fecha Inicio: 2024-04-03
Fecha Fin: 2029-10-31

Líder del proyecto

Innovasjon Norge No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 50M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The overall objective of the proposed broadly protective Filovirus vaccine project is to leverage co-funding from the European Commission to support the development of vaccines that will protect against a range of Filoviruses. Within this viral family, Ebolaviruses and Marburgvirus are endemic to West and Central Africa and cause frequent unpredictable outbreaks of varying size and duration. These outbreaks have significant health and societal impacts on populations in the endemic regions. In order to better prepare for future outbreaks of Zaire ebolavirus and other Filoviruses, it is necessary to develop tools to preventively vaccinate at-risk populations, such as health-care workers, in endemic regions. The impact of such preventive vaccinations would be greatest if the vaccines protected against a broad range of Filoviruses that emerge in those regions. This project therefore aims to support the development of broadly protective Filovirus vaccines for preventive use. This will be achieved through two focussed areas of work, the first being the development of multivalent vaccines composed of single valencies covering different Filoviruses, and secondly the development of a vaccine library comprised of all known Filoviruses. The output of the work under this project will be multivalent vaccines with phase II clinical data to support a pathway to licensure, and individual exemplar candidates from a vaccine library with phase I clinical data. This co-funded grant application seeks to leverage €35m from Horizon Europe, which will be supplemented with €15m from CEPI making a total pool of €50m. Awards to support the project aims will be administered and managed by the CEPI secretariat, and the total project duration will be 66 months. This project builds on the existing partnership between the CEPI and the European Union which seeks to accelerate vaccine development for priority pathogens causing epidemic and pandemic threats collaboratively and effectively.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores